Research Novartis CEO Vas Narasimhan says 'no change of plans'By Healthcare Propulsion StaffJuly 21, 20260 Novartis chief executive officer Vas Narasimhan said on Tuesday he plans to stick around for the Swiss drugmaker’s next phase…
Tech TytoCare scores $25M, appoints new CEO and COOBy Healthcare Propulsion StaffJuly 20, 20260 TytoCare scores $25M, appoints new CEO and COO | MobiHealthNews Skip to main content TOPICS RESOURCES REGIONS MORE Source Link
